{"id":"559329-3714","orgnr":"559329-3714","name":"Techpharma Consulting AB","name_registered_on":"2021-08-02","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2021-08-02","business_description":"Konsultverksamhet inom Life Science.","industries":[{"code":"71122","name":"Teknisk konsultverksamhet inom industriteknik"}],"postal_address":{"street":"Sandbrovägen 9A","postal_code":"18330","city":"TÄBY","country":"SE","municipality":{"code":"0160","name":"Täby"},"county":{"code":"01","name":"Stockholms län"}},"registered_office":{"municipality":{"code":"0180","name":"Stockholm"},"county":{"code":"01","name":"Stockholms län"}},"activity_status":"no_longer_active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"0","name":"< 1 tkr","year":2021},"f_tax":"deregistered","vat":"deregistered","employer":"deregistered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2024-02-01","to":"2025-01-31","framework":"K2","signed_on":"2025-11-09","documents":{"annual_report":"/v1/documents/926340d0-78fd-4970-9ef0-28bb85bd6b58.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/45_3.zip"}},{"from":"2023-02-01","to":"2024-01-31","framework":"K2","signed_on":"2024-08-31","documents":{"annual_report":"/v1/documents/ac4c23c2-e443-4bef-8218-79bd9d622d4d.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/35_2.zip"}},{"from":"2021-08-02","to":"2023-01-31","framework":"K2","signed_on":"2023-08-27","documents":{"annual_report":"/v1/documents/46c63588-f869-4bcf-9134-863fcbfd3ace.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/35_2.zip"}}],"latest_financials":{"from":"2024-02-01","to":"2025-01-31","scope":"company","currency":"SEK","net_sales":0,"other_operating_income":0,"operating_profit":0,"profit_after_financial_items":0,"net_profit":0,"total_assets":25000,"current_assets":25000,"equity":25000,"share_capital":25000,"unrestricted_equity":0,"current_liabilities":0,"cash":25000,"equity_ratio":1,"source":{"annual_report":"2025-01-31","document":"/v1/documents/926340d0-78fd-4970-9ef0-28bb85bd6b58.xhtml"},"anchors":{"cash":{"text":"25 000","suffix":"Summa omsättningstillgångar"},"current_assets":{"text":"25 000","prefix":"omsättningstillgångar"},"current_liabilities":{"text":"0","prefix":"skulder"},"equity":{"text":"25 000","suffix":"Kortfristiga"},"equity_ratio":{"text":"100"},"net_profit":{"text":"0","suffix":"Techpharma"},"net_sales":{"text":"0","suffix":"Förändring"},"operating_profit":{"text":"0","prefix":"Rörelseresultat"},"other_operating_income":{"text":"0","prefix":"rörelseintäkter"},"profit_after_financial_items":{"text":"0","suffix":"Resultat före"},"share_capital":{"text":"25 000","prefix":"utgång"},"total_assets":{"text":"25 000","prefix":"tillgångar"},"unrestricted_equity":{"text":"0","suffix":"Styrelsen"}}},"officers":{"annual_report":"2025-01-31","signed_on":"2025-11-09","signatories":[{"name":"M*****","role":"Styrelseledamot"}]}}